Glanbia Plc · EURONEXT:GL9
Glanbia — Q1 2022 Earnings Presentation
14 slides from Glanbia's earnings presentation, May 5, 2022
Slide 1: Glanbia plc Q1 2022
Glanbia plc Q1 2022 5 May 2022 Group Managing Director Group Finance Director
Slide 2: Important notice
2 Glanbia plc | Q1 2022 IMS presentation Important notice This presentation contains forward-looking statements. These statements have been made by the Directors in good faith based on the information available to them up to the time of their approval of this presentation. Due to the inherent uncert
Slide 3: Performing with purpose
3 Glanbia plc | Q1 2022 IMS presentation Performing with purpose Good consumption and demand trends across the key growth platforms Significant action taken to mitigate inflation and drive growth Delivering strategic agenda Guidance raised in FY 22, Group expects 5% to 10% growth in Adj. EPS*, CC *A
Slide 4: Q1 2022 Performance overview
4 Glanbia plc | Q1 2022 IMS presentation Q1 2022 Performance overview Performance Q1 2022 Revenue Growth (Constant Currency) Volume Price LFL Acquisition Total BRANDED 3.3% 13.4% 16.7% - 16.7% Good demand trends in GPN and GN NS GPN TOTAL 1.7% 13.0% 14.7% 1.0% 15.7% Significant pricing action across
Slide 5: FY 2022 Focus areas
5 Glanbia plc | Q1 2022 IMS presentation FY 2022 Focus areas GPN GN NS Group Sustaining brand momentum across ON Innovation across categories Cash conversion 80%+ Driving lifestyle brand portfolio Driving solutions growth through innovation Investment and shareholder returns and technology developme
Slide 6: FY 2022 Outlook
6 Glanbia plc | Q1 2022 IMS presentation FY 2022 Outlook GPN and NS GPN and NS 80%+ Adj. EPS Double-digit LFL* EBITA growth v PY OCF conversion Growth of 5% to revenue growth v PY 10%, CC *Like-for-like (LFL) excludes current and prior year acquisitions
Slide 7: GPN Q1 2022 Update
7 Glanbia plc | Q1 2022 IMS presentation GPN Q1 2022 Update Branded LFL Revenue Growth 16.7% (Constant Currency) VOLUME 3.3% PRICE 13.4% Strong revenue growth across Americas and International Pricing action across all brands and geographies Optimum Nutrition primary driver of growth Growth across h
Slide 8: Leading brands in performance & lifestyle nutrition
8 Glanbia plc | Q1 2022 IMS presentation Leading brands in performance & lifestyle nutrition Performance Nutrition Healthy Lifestyle Weight Management D2C % GPN Revenue 51.3% 17.4% 17.5% 6.0% Q1 LFL Sales Growth +23.0%cc +26.9%cc -8.5%cc +20.6%cc* US Consumption** +15.8% +14.0% -16.6% - • Driving aw
Slide 9: GN NS Q1 2022 Update
9 Glanbia plc | Q1 2022 IMS presentation GN NS Q1 2022 Update GN NS Revenue Growth 22.4% (Constant Currency) Volume 4.2% Price 14.8% Acquisition 3.4% Strong revenue growth, particularly micro-nutrients Price action taken; pass-through pricing on key material inflation Navigating supply chain challen
Slide 10: GN NS acquisition - Sterling Technology
10 Glanbia plc | Q1 2022 IMS presentation GN NS acquisition - Sterling Technology Summary Acquisition Rationale • Acquired Sterling Technology, • Build out the NS bioactive a US based leading bioactive portfolio solutions business CORE • Complements NS portfolio SOLUTIONS • Consideration $60 million
Slide 11: Finance
Finance Q1 2022 review Mark Garvey Group Finance Director
Slide 12: Q1 2022 - Strong Balance sheet
12 Glanbia plc | Q1 2022 IMS presentation Q1 2022 - Strong Balance sheet Portfolio Shareholder Returns Cash & Debt €307 million from Glanbia €123 million on share Net Debt to Adj. EBITDA Ireland disposal buybacks to-date in 2022 1.52 times $60 million invested in Expect to deliver >80% Sterling Tech
Slide 13: Group well positioned to deliver growth
13 Glanbia plc | Q1 2022 IMS presentation Group well positioned to deliver growth Strong start with Q1 LFL Group revenue up 23.9% Significant actions taken to mitigate inflation and drive strategic agenda Positive trends have continued into Q2 Guidance raised In FY 22, Group expects 5% to 10% growth
Slide 14: Questions
Questions